The pharmaceutical industry is undergoing rapid change to meet increased global competition and the demands of its customers. As science advances, pharma’s focus has shifted from developing and making a limited number of large-volume “blockbuster” drugs to manufacturing a large number of varied therapies (e.g., personalized medicines) targeted to individual patients, patient groups, and global markets.
